The Checkup by Singlecare
JUNE 17, 2024
When over-the-counter (OTC) remedies don’t cut it, your healthcare provider may prescribe Zofran ( ondansetron ), a medication used to treat upset stomach and prevent vomiting—especially when caused by chemotherapy, radiation therapy, and surgery. The blister packs did not adhere to federal packaging requirements.
European Pharmaceutical Review
SEPTEMBER 15, 2023
A modern identity for Janssen The new logo, colors, and font for J&J Innovative Medicine will be rolled out steadily across all company materials, product packaging, and branding assets over time. Branding innovation in the pharmaceutical industry This week, Novartis has also finalised changes to its divisions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
MARCH 15, 2023
It binds to chromatin, which is the braid of DNA and protein packaging within the nucleus; it summons large protein complexes to join it. Menin is a critical part of the cell’s epigenetic mechanism for switching gene activity on and off. The complexes tighten or loosen the coils of DNA, changing gene activity level at that site.
European Pharmaceutical Review
NOVEMBER 4, 2022
Despite advances with targeted and immuno-oncology therapies, chemotherapies remain a cornerstone of cancer treatment for many tumour types – a reflection of their significant anti?tumour While highly effective, taxanes also exhibit several of the typical limitations associated with systemic chemotherapies. tumour effects.
Pharmaceutical Technology
MARCH 30, 2023
On March 27, MSD announced that the combined use of Keytruda with chemotherapy significantly improved progression-free survival versus the chemotherapy alone, as a first-line therapy for advanced or recurrent endometrial carcinoma. This announcement is not the only recent development for Keytruda.
European Pharmaceutical Review
AUGUST 25, 2022
After surgery, strategic combinations of radiotherapy, chemotherapy like temozolomide, and other forms of treatment, such as immunotherapy or the use of an electric field cap, are employed. For example, radiotherapy and chemotherapy together entails up to six month? Two weeks later, patients began standard radiation and chemotherapy.
pharmaphorum
APRIL 16, 2021
GSK decided to stop enrolling patients on the phase 2 INDUCE-3 trial, discontinuing treatment with feladilimab and has also axed the INDUCE-4 phase 2 trial, testing feladilimab versus placebo in combination with Keytruda and chemotherapy. billion signed with Germany’s Merck KGaA.
Expert insights. Personalized for you.
105 
Let's personalize your content